GRTS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 138504 min ago

@ $2.18

Išleistas: 14 vas. 2024 @ 21:06

Grąža: -62.40%

Ankstesnis signalas: vas. 13 - 22:42

Ankstesnis signalas: Pardavimas

Grąža: 3.82 %

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases...

Stats
Šios dienos apimtis	2.24M
Vidutinė apimtis	2.98M
Rinkos kapitalizacija	88.80M
EPS	$0 ( 2024-05-09 )
Kita pelno data	( $-0.320 ) 2024-06-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.660
ATR14	$0.00400 (0.49%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Allen Andrew R	Buy	47 873	Common Stock
2024-05-16	Allen Andrew R	Sell	24 263	Common Stock
2024-05-15	Allen Andrew R	Buy	615 000	Stock Option (Right to Buy)
2024-05-15	Jones Erin	Buy	27 128	Common Stock
2024-05-16	Jones Erin	Sell	13 749	Common Stock

INSIDER POWER
96.52
Last 98 transactions
Buy: 7 577 348 \| Sell: 147 493

Tūris Koreliacija

Ilgas: 0.21 (neutral)

Trumpas: -0.99 (very strong negative)

Signal:(45.278) Neutral

Gritstone Oncology Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
LULU	0.893
EZGO	0.89
ATNF	0.887
AFYA	0.87
SRNE	0.863
QH	0.862
ISSC	0.861
RCMT	0.856
ATRC	0.855
YI	0.854

10 Labiausiai neigiamai susiję koreliacijos
LABP	-0.936
NVEI	-0.921
CURI	-0.918
CENX	-0.918
IDN	-0.916
TH	-0.909
PAYS	-0.908
VFF	-0.898
WIRE	-0.898
STOK	-0.893

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Gritstone Oncology Inc Koreliacija - Valiuta/Žaliavos

-0.07
( neutral )

0.31
( neutral )

0.00
( neutral )

-0.21
( neutral )

Gritstone Oncology Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$1.33M
Bruto pelnas:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2023
Pajamos:	$1.33M
Bruto pelnas:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2022
Pajamos:	$9.27M
Bruto pelnas:	$-6.42M (-69.28 %)
EPS:	$-1.240

FY	2021
Pajamos:	$48.21M
Bruto pelnas:	$48.21M (100.00 %)
EPS:	$-0.965

Financial Reports:

No articles found.

Gritstone Oncology Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.